Cargando…
Enhanced gut barrier integrity sensitizes colon cancer to immune therapy
Oral IL-10 suppressed tumor growth in the APC(min/+) mouse/Bacteroides fragilis colon cancer model while a similar formulation of IL-12 exacerbated disease. In contrast, combined treatment with IL-10 and IL-12 resulted in near-complete tumor eradication and a significant extension of survival. The c...
Autores principales: | Bhutiani, Neal, Li, Qingsheng, Anderson, Charles D., Gallagher, Heather C., De Jesus, Magdia, Singh, Rajbir, Jala, Venkatkrishna R., Fraig, Mostafa, Gu, Tao, Egilmez, Nejat K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204984/ https://www.ncbi.nlm.nih.gov/pubmed/30377564 http://dx.doi.org/10.1080/2162402X.2018.1498438 |
Ejemplares similares
-
Temporospatial shifts within commercial laboratory mouse gut microbiota impact experimental reproducibility
por: Mandal, Rabindra K., et al.
Publicado: (2020) -
Berry anthocyanidins inhibit intestinal polyps and colon tumors by modulation of Src, EGFR and the colon inflammatory environment
por: Mudd, Ashley M., et al.
Publicado: (2021) -
IFNβ-producing CX3CR1(+) macrophages promote T-regulatory cell expansion and tumor growth in the APC(min/+) / Bacteroides fragilis colon cancer model
por: Gu, Tao, et al.
Publicado: (2019) -
Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae
por: Liu, Yingru, et al.
Publicado: (2018) -
Modulating gut immunity and neoplasia with oral cytokine adjuvants
por: Ozbilge, Hatice, et al.
Publicado: (2015)